Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib MoA study in plaque psoriasis
NCT01710046Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tofacitinib oral solution in plaque psoriasis, sponsored by Pfizer. Started Mar 2013; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01710046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01710046.